Search filters

List of works by Federico Garrido

"Hard" and "soft" lesions underlying the HLA class I alterations in cancer cells: implications for immunotherapy

scientific article published on July 2010

A Combination of Positive Tumor HLA-I and Negative PD-L1 Expression Provides an Immune Rejection Mechanism in Bladder Cancer

scientific article published on 22 April 2019

A novel preclinical murine model of immune-mediated metastatic dormancy.

scientific article published on 25 June 2014

A polymorphism in the interleukin-10 promoter affects the course of disease in patients with clear-cell renal carcinoma

scientific article published on 21 November 2008

Alterations of HLA class I expression in human melanoma xenografts in immunodeficient mice occur frequently and are associated with higher tumorigenicity.

scientific article published on 9 May 2009

Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy

scientific article published on 11 June 2008

Analysis of HLA expression in human tumor tissues

scientific article

Analysis of HLA-ABC locus-specific transcription in normal tissues.

scientific article

Analysis of HLA-E expression in human tumors

scientific article published on 30 January 2003

Analysis of NK cells and chemokine receptors in tumor infiltrating CD4 T lymphocytes in human renal carcinomas

scientific article published on 11 May 2005

Association between C13ORF31, NOD2, RIPK2 and TLR10 polymorphisms and urothelial bladder cancer

scientific article published on 12 April 2012

Bacillus Calmette-Guerin immunotherapy of bladder cancer induces selection of human leukocyte antigen class I-deficient tumor cells.

scientific article

Cancer immune escape: MHC expression in primary tumours versus metastases

scientific article published on 01 October 2019

Cancer immune escape: implications for immunotherapy, Granada, Spain, October 3-5, 2011

scientific article published on 21 February 2012

Changes in activatory and inhibitory natural killer (NK) receptors may induce progression to multiple myeloma: implications for tumor evasion of T and NK cells

scientific article published on 04 July 2009

Characterization of HLA class I altered phenotypes in a panel of human melanoma cell lines

scientific article

Colorectal Cancer Classification and Cell Heterogeneity: A Systems Oncology Approach

scientific article

Complete loss of HLA class I antigen expression on melanoma cells: a result of successive mutational events.

scientific article

Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer

scientific article published in February 2005

Different regulation of PKC isoenzymes and MAPK by PSK and IL-2 in the proliferative and cytotoxic activities of the NKL human natural killer cell line.

scientific article published on 17 October 2002

Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines

scientific article

Distribution of HLA class I altered phenotypes in colorectal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.

scientific article

Expression of MHC class I, MHC class II, and cancer germline antigens in neuroblastoma

scientific article published on 24 September 2004

Frequent HLA class I alterations in human prostate cancer: molecular mechanisms and clinical relevance.

scientific article published on 26 November 2015

Frequent loss of heterozygosity in the β2-microglobulin region of chromosome 15 in primary human tumors

scientific article published on November 18, 2010

Generation of MHC class I diversity in primary tumors and selection of the malignant phenotype.

scientific article

Genetic polymorphisms of RANTES, IL1-A, MCP-1 and TNF-A genes in patients with prostate cancer

scientific article

Genome-wide differential genetic profiling characterizes colorectal cancers with genetic instability and specific routes to HLA class I loss and immune escape

scientific article published on November 10, 2011

Genomic loss of HLA alleles may affect the clinical outcome in low-risk myelodysplastic syndrome patients

scientific article published on 11 December 2018

HLA Class-I Expression and Cancer Immunotherapy

scientific article published on 01 January 2019

HLA Class-II Expression in Human Tumors

scientific article published on 01 January 2019

HLA and melanoma: multiple alterations in HLA class I and II expression in human melanoma cell lines from ESTDAB cell bank.

scientific article

HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15.

scientific article published on 25 August 2018

HLA class I antigen abnormalities and immune escape by malignant cells.

scientific article

HLA class I expression in metastatic melanoma correlates with tumor development during autologous vaccination.

scientific article

HLA class I loss and PD-L1 expression in lung cancer: impact on T-cell infiltration and immune escape.

scientific article published on 19 December 2017

High frequency of HLA-B44 allelic losses in human solid tumors

scientific article published on 01 October 2003

High frequency of homozygosity of the HLA region in melanoma cell lines reveals a pattern compatible with extensive loss of heterozygosity

scholarly article by Teresa Rodriguez et al published 1 October 2004 in Cancer Immunology, Immunotherapy

High incidence of CTLA-4 AA (CT60) polymorphism in renal cell cancer

IFN inducibility of major histocompatibility antigens in tumors

scientific article published on January 2008

Identification of different tumor escape mechanisms in several metastases from a melanoma patient undergoing immunotherapy

scientific article published on 19 April 2006

Identification of the protein components of protein-bound polysaccharide (PSK) that interact with NKL cells.

scientific article

Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma

scientific article published on 16 July 2013

Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumors

scientific article

Immunotherapy eradicates metastases with reversible defects in MHC class I expression

scientific article published on 8 May 2011

Impact of interleukin-18 polymorphisms-607 and -137 on clinical characteristics of renal cell carcinoma patients

scientific article published on 12 January 2010

Impaired surface antigen presentation in tumors: implications for T cell-based immunotherapy.

scientific article

Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes

scientific article published on July 26, 2012

International conference: progress in vaccination against cancer-2006 (PIVAC 6), Granada, Spain.

scientific article published on 21 March 2007

Introduction

Involvement of the chaperone tapasin in HLA-B44 allelic losses in colorectal tumors

scientific article published on 01 February 2005

LOH at 6p21.3 region and HLA class I altered phenotypes in bladder carcinomas

scientific article published on 17 May 2006

Late pulmonary metastases of renal cell carcinoma immediately after post-transplantation immunosuppressive treatment: a case report

scientific article published on 18 April 2008

Leukocyte infiltrate in gastrointestinal adenocarcinomas is strongly associated with tumor microsatellite instability but not with tumor immunogenicity

scientific article published on 13 March 2011

Low frequency of HLA haplotype loss associated with loss of heterozygocity in chromosome region 6p21 in clear renal cell carcinomas

scientific article published on 01 April 2004

MHC Intratumoral Heterogeneity May Predict Cancer Progression and Response to Immunotherapy.

scientific article published on 29 January 2018

MHC class I antigens and immune surveillance in transformed cells.

scientific article published on January 2007

MHC class I antigens, immune surveillance, and tumor immune escape.

scientific article

MHC class I molecules act as tumor suppressor genes regulating the cell cycle gene expression, invasion and intrinsic tumorigenicity of melanoma cells.

scientific article published on 4 January 2012

MHC class I-deficient metastatic tumor variants immunoselected by T lymphocytes originate from the coordinated downregulation of APM components.

scientific article published in September 2003

MHC/HLA Class I Loss in Cancer Cells

scientific article published on 01 January 2019

Metastases in immune-mediated dormancy: a new opportunity for targeting cancer

scientific article

Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21

scientific article published on 28 June 2002

Negative Clinical Evolution in COVID-19 Patients Is Frequently Accompanied With an Increased Proportion of Undifferentiated Th Cells and a Strong Underrepresentation of the Th1 Subset

scientific article published on 26 November 2020

Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations

scientific article published on 20 May 2008

Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon‐mediated rejection genes

scientific article published on November 9, 2011

Rejection versus escape: the tumor MHC dilemma

scientific article published on 31 December 2016

Restoration of MHC-I on Tumor Cells by Fhit Transfection Promotes Immune Rejection and Acts as an Individualized Immunotherapeutic Vaccine

scientific article published on 12 June 2020

Role of altered expression of HLA class I molecules in cancer progression.

scientific article published on January 2007

Role of glutathione in the induction of apoptosis and c-fos and c-jun mRNAs by oxidative stress in tumor cells.

scientific article published on May 2004

T lymphocytes restrain spontaneous metastases in permanent dormancy.

scientific article published on 14 February 2014

TAP1 and TAP2 polymorphisms and their linkage disequilibrium with HLA-DR, -DP, and -DQ in an eastern Andalusian population

scientific article

Targetless T cells in cancer immunotherapy

scientific article published on 19 April 2016

The Escape of Cancer from T Cell-Mediated Immune Surveillance: HLA Class I Loss and Tumor Tissue Architecture

scientific article published on 27 February 2017

The absence of HLA class I expression in non-small cell lung cancer correlates with the tumor tissue structure and the pattern of T cell infiltration

scientific article published on 27 October 2016

The escape of cancer from T lymphocytes: immunoselection of MHC class I loss variants harboring structural-irreversible "hard" lesions

scientific article published on 13 July 2010

The immunomodulator PSK induces in vitro cytotoxic activity in tumour cell lines via arrest of cell cycle and induction of apoptosis

scientific article published in 2008

The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape.

scientific article published on 7 April 2004

The transition from HLA-I positive to HLA-I negative primary tumors: the road to escape from T-cell responses

scientific article published on 19 March 2018

The tumour suppressor Fhit positively regulates MHC class I expression on cancer cells

scientific article published on May 23, 2012

The urgent need to recover MHC class I in cancers for effective immunotherapy

scientific article

Total loss of HLA class I expression on a melanoma cell line after growth in nude mice in absence of autologous antitumor immune response.

scientific article

Tumor genetic alterations and features of the immune microenvironment drive myelodysplastic syndrome escape and progression

scientific article published on 08 November 2019

Upregulation of HLA Class I Expression on Tumor Cells by the Anti-EGFR Antibody Nimotuzumab.

scientific article published on 6 October 2017

VEGF polymorphisms are not associated with an increased risk of developing renal cell carcinoma in Spanish population

scientific article published on 13 October 2012